Bavituximab, known as TRWH-783, represents an innovative therapeutic approach targeting phosphatidylserine (PS). PS is usually an cellular lipid found on cell membranes; however, it's often exposed on the external of https://socialmediainuk.com/story26631159/bavituximab-a-novel-approach-to-tumor-management